{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:45:13Z","timestamp":1761965113297,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.coph.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T17:54:42Z","timestamp":1560534882000},"page":"82-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Transcription inhibitors and inflammatory cell activity"],"prefix":"10.1016","volume":"46","author":[{"given":"Gaetano","family":"Caramori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Coppolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Francesco","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfio","family":"Proietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Mumby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2019.05.006_bib0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coph.2019.05.006_bib0010","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1042\/CS20160487","article-title":"Cellular and molecular mechanisms of asthma and COPD","volume":"131","author":"Barnes","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.coph.2019.05.006_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-016-0561-5","article-title":"COPD immunopathology","volume":"38","author":"Caramori","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.coph.2019.05.006_bib0020","unstructured":"Global Initiative for Asthma. Global strategy for Asthma Management and Prevention. Last update 2018, 1-162. ginasthma.org."},{"key":"10.1016\/j.coph.2019.05.006_bib0025","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Last update 2018, 1-123. goldcopd.org."},{"key":"10.1016\/j.coph.2019.05.006_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-065X.2011.01020.x","article-title":"Pathophysiology of allergic inflammation","volume":"242","author":"Barnes","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2019.05.006_bib0035","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/labinvest.3700456","article-title":"Transcription factors in airway diseases","volume":"86","author":"Barnes","year":"2006","journal-title":"Lab Invest"},{"year":"2019","series-title":"Transcription Factors","author":"Caramori","key":"10.1016\/j.coph.2019.05.006_bib0040"},{"key":"10.1016\/j.coph.2019.05.006_bib0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2019.05.006_bib0050","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1055\/s-0032-1326958","article-title":"New drugs for asthma","volume":"33","author":"Barnes","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.coph.2019.05.006_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/15419061.2013.775257","article-title":"Role of transcription factors in the pathogenesis of asthma and COPD","volume":"20","author":"Caramori","year":"2013","journal-title":"Cell Commun Adhes"},{"key":"10.1016\/j.coph.2019.05.006_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4049\/jimmunol.165.1.10","article-title":"Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on STAT6 but not STAT4","volume":"165","author":"Zhang","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2019.05.006_bib0065","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1038\/sj.onc.1209937","article-title":"Post-translational modifications regulating the activity and function of the nuclear factor kappaB pathway","volume":"25","author":"Perkins","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.coph.2019.05.006_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc3204","article-title":"The diverse and complex roles of NF-\u03baB subunits in cancer","volume":"12","author":"Perkins","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coph.2019.05.006_bib0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jaci.2011.03.045","article-title":"I\u03baB kinase-driven nuclear factor-\u03baB activation in patients with asthma and chronic obstructive pulmonary disease","volume":"128","author":"Gagliardo","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2019.05.006_bib0080","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/emmm.201201650","article-title":"Defining critical roles for NF-\u03baB p65 and type I interferon in innate immunity to rhinovirus","volume":"4","author":"Bartlett","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.coph.2019.05.006_bib0085","first-page":"12115","article-title":"Nuclear factor-\u03baB mediates the phenotype switching of airway smooth muscle cells in a murine asthma model","volume":"8","author":"Qiu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.coph.2019.05.006_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090298","article-title":"Tumour necrosis factor-\u03b1 regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-\u03baB and AP-1","volume":"9","author":"Kankaanranta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2019.05.006_bib0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00005-016-0405-y","article-title":"Transcription factor NF-\u03baB: an update on intervention strategies","volume":"64","author":"Panday","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.coph.2019.05.006_bib0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.intimp.2018.05.004","article-title":"Fisetin inhibits the generation of inflammatory mediators in interleukin-1\u03b2-induced human lung epithelial cells by suppressing the NF-\u03baB and ERK1\/2 pathways","volume":"60","author":"Peng","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08923973.2017.1414836","article-title":"Anti-inflammatory effects of embelin in A549 cells and human asthmatic airway epithelial tissues","volume":"40","author":"Lee","year":"2018","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.coph.2019.05.006_bib0110","first-page":"208","article-title":"Fisetin-treatment alleviates airway inflammation through inhbition of MyD88\/NF-\u03baB signaling pathway","volume":"42","author":"Huang","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.coph.2019.05.006_bib0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1254\/jphs.14037FP","article-title":"Salidroside attenuates allergic airway inflammation through negative regulation of nuclear factor-kappa B and p38 mitogen-activated protein kinase","volume":"126","author":"Yan","year":"2014","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.coph.2019.05.006_bib0120","first-page":"1141","article-title":"Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD","volume":"5","author":"Caramori","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.coph.2019.05.006_bib0125","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrd1132","article-title":"Targeting JNK for therapeutic benefit: from junk to gold?","volume":"2","author":"Manning","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2019.05.006_bib0130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.coph.2004.03.009","article-title":"The p38 MAP kinase pathway as a therapeutic target in inflammatory disease","volume":"4","author":"Saklatvala","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molcel.2011.06.016","article-title":"Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding","volume":"43","author":"Biddie","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.coph.2019.05.006_bib0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1677\/joe.0.1780347","article-title":"Corticosteroid-insensitive asthma: molecular mechanisms","volume":"178","author":"Adcock","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/j.coph.2019.05.006_bib0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejphar.2004.11.040","article-title":"Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125","volume":"506","author":"Nath","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0150","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1021\/jm5004733","article-title":"Small molecule inhibitors targeting Activator Protein 1 (AP-1): miniperspective","volume":"57","author":"Ye","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2019.05.006_bib0155","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cell.2012.09.044","article-title":"STATs shape the active enhancer landscape of T cell populations","volume":"151","author":"Vahedi","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.coph.2019.05.006_bib0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12026-011-8205-2","article-title":"Transcriptional regulation by STAT6","volume":"50","author":"Goenka","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.coph.2019.05.006_bib0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-9255-9-5","article-title":"STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects","volume":"9","author":"Tomita","year":"2012","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.coph.2019.05.006_bib0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1744-313X.2011.01051.x","article-title":"Association of ORMDL3, STAT6 and TBXA2R gene polymorphisms with asthma","volume":"39","author":"Kavalar","year":"2012","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.coph.2019.05.006_bib0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1752-0509-6-105","article-title":"Chemoattraction of macrophages by secretory molecules derived from cells expressing the signal peptide of eosinophil cationic protein","volume":"6","author":"Liu","year":"2012","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.coph.2019.05.006_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08923971003699026","article-title":"Antigen exposure causes activations of signal transducer and activator of transcription 6 (STAT6) and STAT1, but not STAT3, in lungs of sensitized mice","volume":"33","author":"Chiba","year":"2011","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.coph.2019.05.006_bib0185","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/thx.56.9.696","article-title":"Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway","volume":"56","author":"Turlej","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.coph.2019.05.006_bib0190","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1172\/JCI80911","article-title":"High IFN-\u03b3 and low SLPI mark severe asthma in mice and humans","volume":"125","author":"Raundhal","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2019.05.006_bib0195","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94580","article-title":"Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias","volume":"2","author":"Gauthier","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.coph.2019.05.006_bib0200","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jaci.2017.08.020","article-title":"TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status","volume":"141","author":"Wisniewski","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2019.05.006_bib0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coph.2019.05.006_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128757","article-title":"Effect of JAK inhibitors on release of CXCL9, CXCL10 and CXCL11 from human airway epithelial cells","volume":"10","author":"Fenwick","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2019.05.006_bib0215","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11033-016-4007-x","article-title":"Identifying a biomarker network for corticosteroid resistance in asthma from bronchoalveolar lavage samples","volume":"43","author":"Vargas","year":"2016","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.coph.2019.05.006_bib0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao2151","article-title":"Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma","volume":"10","author":"Dengler","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2019.05.006_bib0225","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.coph.2012.01.015","article-title":"Antioxidant pharmacological therapies for COPD","volume":"12","author":"Rahman","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0230","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.201011-1780OC","article-title":"Transforming growth factor-\u03b2 and nuclear factor E2\u2013related factor 2 regulate antioxidant responses in airway smooth muscle cells: role in asthma","volume":"184","author":"Michaeloudes","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coph.2019.05.006_bib0235","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.coph.2019.05.006_bib0240","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/1440-1681.12384","article-title":"Curcumin ameliorates asthmatic airway inflammation by activating nuclear factor-E2-related factor 2\/haem oxygenase (HO)-1 signalling pathway","volume":"42","author":"Liu","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.coph.2019.05.006_bib0245","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.intimp.2018.11.003","article-title":"Aloperine suppresses allergic airway inflammation through NF-\u03baB, MAPK, and Nrf2\/HO-1 signaling pathways in mice","volume":"65","author":"Wang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12931-015-0253-z","article-title":"Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways","volume":"16","author":"Brown","year":"2015","journal-title":"Respir Res"},{"key":"10.1016\/j.coph.2019.05.006_bib0255","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jaip.2016.03.012","article-title":"A randomized controlled trial of the effect of broccoli sprouts on antioxidant gene expression and airway Inflammation in asthmatics","volume":"4","author":"Sudini","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coph.2019.05.006_bib0260","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.117.014753","article-title":"Transcription actor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach","volume":"70","author":"Cuadrado","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.coph.2019.05.006_bib0265","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1165\/rcmb.2007-0424OC","article-title":"Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease","volume":"39","author":"Suzuki","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coph.2019.05.006_bib0270","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1172\/JCI45144","article-title":"Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients","volume":"121","author":"Malhotra","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2019.05.006_bib0275","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1152\/physiolgenomics.00027.2012","article-title":"NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease","volume":"44","author":"Sandford","year":"2012","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.coph.2019.05.006_bib0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/ars.2012.4754","article-title":"The predicted molecular weight of nrf2: it is what it is not","volume":"18","author":"Lau","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.coph.2019.05.006_bib0285","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3389\/fphar.2018.01001","article-title":"Isoliquiritigenin inhibits cigarette smoke-induced COPD by attenuating inflammation and oxidative stress via the regulation of the Nrf2 and NF-\u03baB signaling pathways","volume":"9","author":"Yu","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0290","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.intimp.2015.07.011","article-title":"Forsythiaside inhibits cigarette smoke-induced lung inflammation by activation of Nrf2 and inhibition of NF-\u03baB","volume":"28","author":"Cheng","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0295","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12931-018-0766-3","article-title":"Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: the role of Nrf2 antioxidant system in preventing oxidative stress","volume":"19","author":"Dianat","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.coph.2019.05.006_bib0300","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3892\/mmr.2017.6700","article-title":"Sulforaphane increases Nrf2 expression and protects alveolar epithelial cells against injury caused by cigarette smoke extract","volume":"16","author":"Jiao","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.coph.2019.05.006_bib0305","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.taap.2018.10.005","article-title":"Andrographolide simultaneously augments Nrf2 antioxidant defense and facilitates autophagic flux blockade in cigarette smoke-exposed human bronchial epithelial cells","volume":"360","author":"Tan","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0310","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.intimp.2016.10.011","article-title":"Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2","volume":"40","author":"Li","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coph.2019.05.006_bib0315","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.117.241794","article-title":"Characterization of the potent, selective Nrf2 activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in cellular and in vivo models of pulmonary oxidative stress","volume":"363","author":"Yonchuk","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2019.05.006_bib0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163716","article-title":"Lack of effect of oral sulforaphane administration on Nrf2 expression in COPD: a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Wise","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2019.05.006_bib0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20050466","article-title":"Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression","volume":"203","author":"Ito","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2019.05.006_bib0330","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jaci.2010.02.003","article-title":"A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease","volume":"125","author":"Marwick","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2019.05.006_bib0335","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1378\/chest.09-2363","article-title":"Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD","volume":"137","author":"Ford","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.coph.2019.05.006_bib0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/jphi.JPHI_58_17","article-title":"A prospective randomized controlled study: theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients","volume":"7","author":"Ranjani","year":"2017","journal-title":"Int J Pharm Investig"},{"key":"10.1016\/j.coph.2019.05.006_bib0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.chest.2016.04.011","article-title":"Oral low-dose theophylline on top of inhaled fluticasone-salmeterol does not reduce exacerbations in patients with severe COPD: a pilot clinical trial","volume":"150","author":"Cos\u00edo","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.coph.2019.05.006_bib0350","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.2018.14432","article-title":"Effect of theophylline as adjunct to inhaled corticosteroids on exacerbations in patients with COPD: a randomized clinical trial","volume":"320","author":"Devereux","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2019.05.006_bib0355","article-title":"Oral theophylline for chronic obstructive pulmonary disease","volume":"4","author":"Ram","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2019.05.006_bib0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1094-5539(03)00070-1","article-title":"Pharmacology of airway inflammation in asthma and COPD","volume":"16","author":"Caramori","year":"2003","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218301437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218301437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:50:18Z","timestamp":1761461418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489218301437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":72,"alternative-id":["S1471489218301437"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2019.05.006","relation":{},"ISSN":["1471-4892"],"issn-type":[{"type":"print","value":"1471-4892"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcription inhibitors and inflammatory cell activity","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}